These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos. Bianchi C; Bianchi T Turk Patoloji Derg; 2018; 34(2):190-193. PubMed ID: 28272659 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma. Vivero M; Bueno R; Chirieac LR Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745 [TBL] [Abstract][Full Text] [Related]
7. Almost half of women with malignant mesothelioma were exposed to asbestos at home through their husbands or sons. Langhoff MD; Kragh-Thomsen MB; Stanislaus S; Weinreich UM Dan Med J; 2014 Sep; 61(9):A4902. PubMed ID: 25186542 [TBL] [Abstract][Full Text] [Related]
8. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases. Pavlisko EN; Liu B; Green C; Sporn TA; Roggli VL Am J Surg Pathol; 2020 Mar; 44(3):293-304. PubMed ID: 31876584 [TBL] [Abstract][Full Text] [Related]
9. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Attanoos RL; Thomas DH; Gibbs AR Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258 [TBL] [Abstract][Full Text] [Related]
10. The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan. Nakashima K; Demura Y; Oi M; Tabata M; Tada T; Shiozaki K; Akai M; Ishizuka T Intern Med; 2021 Mar; 60(5):771-775. PubMed ID: 33055477 [TBL] [Abstract][Full Text] [Related]
12. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects. Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567 [TBL] [Abstract][Full Text] [Related]
13. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues. Markowitz S Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma. Kaya H; Sezgı C; Tanrıkulu AC; Taylan M; Abakay O; Sen HS; Abakay A; Kucukoner M; Kapan M Neoplasma; 2014; 61(4):433-8. PubMed ID: 24645844 [TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma. Berardi R; Fiordoliva I; De Lisa M; Ballatore Z; Caramanti M; Morgese F; Savini A; Rinaldi S; Torniai M; Tiberi M; Ferrini C; Onofri A; Cascinu S Tumori; 2016; 102(2):190-5. PubMed ID: 26893272 [TBL] [Abstract][Full Text] [Related]
16. Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma. Alchami FS; Attanoos RL; Bamber AR J Clin Pathol; 2017 Feb; 70(2):179-182. PubMed ID: 27798081 [TBL] [Abstract][Full Text] [Related]
17. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival. Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273 [TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009. Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956 [TBL] [Abstract][Full Text] [Related]
19. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study. Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425 [TBL] [Abstract][Full Text] [Related]